Puma Biotechnology Executives Sell Shares Amid Ongoing Company Challenges

PUMA BIOTECHNOLOGY, INC. (PBYI) has announced that Director, President, and CEO Alan H. Auerbach has sold 25,592 shares at $3.53 each on July 8, 2025, and 21,580 shares at $3.54 each on July 9, 2025. Similarly, Director Douglas M. Hunt has sold 4,374 shares at $3.53 each on July 8, 2025, and 3,443 shares at $3.54 each on July 9, 2025. Chief Financial Officer Maxim O. Nougues has sold 5,587 shares at $3.53 each on July 8, 2025, and 3,935 shares at $3.54 each on July 9, 2025.